| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$38,978 ) |
| | 2024 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R21AI146729 | New Drug Leads for Resistant Visceral Leishmaniasis | 000 | 2 | NIH | 10/23/2023 | -$7,709 |
| | 2024 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01AI132579 | Nano-carrier Formulations for Targeted Drug Delivery and Malaria Radical Cure | 000 | 5 | NIH | 10/30/2023 | -$31,269 |
|
| Issue Date FY: 2023 ( Subtotal = $2,181,491 ) |
| | 2023 | 2023 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | S10OD034237 | An Automated Compound Management System for Small Molecule Drug Discovery | 000 | 1 | NIH | 8/2/2023 | $1 |
| | 2023 | 2023 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | UG3AR083022 | Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals | 000 | 1 | NIH | 8/30/2023 | $835,062 |
| | 2023 | 2023 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | S10OD034237 | An Automated Compound Management System for Small Molecule Drug Discovery | 000 | 1 | NIH | 8/2/2023 | $1,038,535 |
| | 2023 | 2023 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | UG3AR083022 | Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals | 000 | 1 | NIH | 8/30/2023 | $1 |
| | 2023 | 2023 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA047924 | Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS | 000 | 4 | NIH | 4/11/2023 | $791,611 |
| | 2023 | 2023 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA047924 | Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS | 001 | 4 | NIH | 5/25/2023 | $148,255 |
| | 2023 | 2022 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01NS124037 | Glial Involvement in REDOX Homeostasis in the Substantia Nigra | 000 | 2 | NIH | 5/29/2023 | $0 |
| | 2023 | 2022 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01NS124037 | Glial Involvement in REDOX Homeostasis in the Substantia Nigra | 002 | 2 | NIH | 6/28/2023 | -$417,837 |
| | 2023 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R21NS124209 | Cell-type-specific contributions to cortical dysfunction in frontotemporal dementia | 003 | 1 | NIH | 6/28/2023 | -$14,679 |
| | 2023 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R21NS124209 | Cell-type-specific contributions to cortical dysfunction in frontotemporal dementia | 001 | 1 | NIH | 6/20/2023 | -$117,253 |
| | 2023 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R21NS124209 | Cell-type-specific contributions to cortical dysfunction in frontotemporal dementia | 000 | 1 | NIH | 12/12/2022 | $0 |
| | 2023 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | F99AG068428 | Omic profiling of vulnerable synapses in age-related neurodegeneration | 000 | 2 | NIH | 6/20/2023 | -$33,120 |
| | 2023 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01NS101958 | Transcriptional regulation of metabolism in neurons | 000 | 6 | NIH | 5/5/2023 | -$47,696 |
| | 2023 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01MH110681 | Cellular Mechanism of Synchrony Impairments in Schizophrenia | 000 | 5 | NIH | 9/8/2023 | -$1,389 |
|
| Issue Date FY: 2022 ( Subtotal = $1,419,511 ) |
| | 2022 | 2022 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01NS124037 | Glial Involvement in REDOX Homeostasis in the Substantia Nigra | 000 | 2 | NIH | 5/4/2022 | $660,181 |
| | 2022 | 2022 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA047924 | Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS | 000 | 3 | NIH | 5/25/2022 | $784,203 |
| | 2022 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R21NS124209 | Cell-type-specific contributions to cortical dysfunction in frontotemporal dementia | 000 | 1 | NIH | 9/8/2022 | $0 |
| | 2022 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01AI132579 | Nano-carrier Formulations for Targeted Drug Delivery and Malaria Radical Cure | 000 | 5 | NIH | 7/28/2022 | $0 |
| | 2022 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01CA183921 | Targeting GLI-dependent Transcription by GANT61 in Colon Cancer | 000 | 5 | NIH | 6/29/2022 | -$24,873 |
| | 2022 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA038635 | Opioid Ligands for the treatment of Alzheimer's Disease (Administrative Supplement on Parent Grant R01DA038635) | 000 | 5 | NIH | 7/21/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,926,125 ) |
| | 2021 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA047924 | Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS | 000 | 2 | NIH | 4/2/2021 | $794,235 |
| | 2021 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01NS124037 | Glial Involvement in REDOX Homeostasis in the Substantia Nigra | 000 | 1 | NIH | 6/10/2021 | $665,920 |
| | 2021 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R21NS124209 | Cell-type-specific contributions to cortical dysfunction in frontotemporal dementia | 000 | 1 | NIH | 6/22/2021 | $594,048 |
| | 2021 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | F99AG068428 | Omic profiling of vulnerable synapses in age-related neurodegeneration | 000 | 2 | NIH | 8/10/2021 | $46,036 |
| | 2021 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R21AI146729 | New Drug Leads for Resistant Visceral Leishmaniasis | 000 | 2 | NIH | 5/11/2021 | $269,027 |
| | 2021 | 2021 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01NS101958 | Transcriptional regulation of metabolism in neurons | 000 | 6 | NIH | 5/3/2021 | $423,859 |
| | 2021 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01CA183921 | Targeting GLI-dependent Transcription by GANT61 in Colon Cancer | 000 | 5 | NIH | 4/28/2021 | $0 |
| | 2021 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA038635 | Opioid Ligands for the treatment of Alzheimer's Disease (Administrative Supplement on Parent Grant R01DA038635) | 000 | 5 | NIH | 6/28/2021 | $0 |
| | 2021 | 2018 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01AI132579 | Nano-carrier Formulations for Targeted Drug Delivery and Malaria Radical Cure | 001 | 3 | NIH | 5/5/2021 | $133,000 |
|
| Issue Date FY: 2020 ( Subtotal = $3,129,004 ) |
| | 2020 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | F99AG068428 | Omic profiling of vulnerable synapses in age-related neurodegeneration | 000 | 1 | NIH | 8/28/2020 | $47,020 |
| | 2020 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA047924 | Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS | 001 | 1 | NIH | 9/22/2020 | $0 |
| | 2020 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA047924 | Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS | 000 | 1 | NIH | 6/26/2020 | $805,690 |
| | 2020 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R21AI146729 | New Drug Leads for Resistant Visceral Leishmaniasis | 000 | 1 | NIH | 6/11/2020 | $318,945 |
| | 2020 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01AI132579 | Nano-carrier Formulations for Targeted Drug Delivery and Malaria Radical Cure | 000 | 5 | NIH | 6/9/2020 | $728,482 |
| | 2020 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01NS101958 | Transcriptional regulation of metabolism in neurons | 000 | 5 | NIH | 3/25/2020 | $435,080 |
| | 2020 | 2020 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01MH110681 | Cellular Mechanism of Synchrony Impairments in Schizophrenia | 000 | 5 | NIH | 4/9/2020 | $793,787 |
|
| Issue Date FY: 2019 ( Subtotal = $4,779,399 ) (Continued on the next page) |
| | 2019 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01NS101958 | Transcriptional regulation of metabolism in neurons | 000 | 4 | NIH | 3/21/2019 | $434,665 |
| | 2019 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01AI132579 | Nano-carrier Formulations for Targeted Drug Delivery and Malaria Radical Cure | 004 | 4 | NIH | 6/7/2019 | $742,840 |
| | 2019 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01MH110681 | Cellular Mechanism of Synchrony Impairments in Schizophrenia | 002 | 4 | NIH | 4/19/2019 | $807,074 |
| | 2019 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA038635 | Opioid Ligands for the treatment of Alzheimer's Disease (Administrative Supplement on Parent Grant R01DA038635) | 001 | 5 | NIH | 6/11/2019 | $527,409 |
| | 2019 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01DA038635 | Opioid Ligands for the treatment of Alzheimer's Disease (Administrative Supplement on Parent Grant R01DA038635) | 000 | 5 | NIH | 6/10/2019 | $880,230 |
| | 2019 | 2019 | SOUTHERN RESEARCH INSTITUTE | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R01CA183921 | Targeting GLI-dependent Transcription by GANT61 in Colon Cancer | 000 | 5 | NIH | 1/7/2019 | $532,166 |
|
